CareersPipelineCollaboration RareInnovation SVGOMG The best SVG optimizer and minifier Open SVG Paste markup Demo Contribute SVGOMG provides you several options to clean and compress your SVG files. Clean up, remove, merge, minify. Upload or copy the source of your SVG to get started! 947 bytes → 267 bytes 28.19% Finance peopleAdvance treatment Skip to main contentSkip to navigationSkip to search
HNSA   ( ,  %) SEK
Quotes are delayed 15 minutes

Some non-regulatory announcements are only available in English. All announcements required under applicable law, regulation or code are available in English and Swedish.

2025

19 Jun 2025, 01:20 | Regulatory
Hansa Biopharma has carried out a directed cash share issue of approx. mSEK 232 and entered into binding agreement to restructure debt held by NovaQuest, including set-off issue of USD 14.9 million
18 Jun 2025, 17:35 | Regulatory
Hansa Biopharma intends to carry out directed share issue of approximately 10 million shares and has entered into non-binding terms with NovaQuest to restructure debt
11 Jun 2025, 08:40
Hansa Biopharma to attend BIO International Convention
9 Jun 2025, 08:00
Hansa Biopharma to Host Science Deep Dive Virtual Investor Event on Guillain-Barré Syndrome on June 16, 2025
26 May 2025, 18:40 | Regulatory
Hansa Biopharma plans restructuring to optimize resource allocation and improve operational efficiency
26 May 2025, 07:00 | Regulatory
Notice to Annual General Meeting in Hansa Biopharma AB (publ)
14 May 2025, 08:00
Hansa Biopharma data at the 2025 PNS Annual Meeting demonstrates potential of imlifidase in the treatment of GBS
13 May 2025, 08:00
Hansa Biopharma appoints Maria Törnsén as Chief Operating Officer and President U.S.
Load more

E-mail

Sign up to receive updates on the latest company news and filings

Choose type

I consent to Hansa Biopharma handling my personal data. See our Privacy Policy for information about how we handle personal data.

Thank you. You will get an e-mail message to activate your subscription.